Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension

Hypertension

Volumn 45, Issue 4 SUPPL., 2005, Pages 705-709

  Allahdadi, Kyan J ^a   Walker, Benjimen R ^a   Kanagy, Nancy L ^a,b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Arteries; Rats; Sleep apnea syndromes

Indexed keywords

CALCIUM; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; BLOOD PRESSURE; BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; CONFERENCE PAPER; CONTROLLED STUDY; DENSITOMETRY; HYPERCAPNIA; HYPERTENSION; HYPOXIA; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SIMULATION; SLEEP APNEA SYNDROME; VASOCONSTRICTION;

ANIMALS; ANOXIA; BLOOD PRESSURE; CALCIUM; ENDOTHELIN-1; HYPERTENSION; MALE; MESENTERIC ARTERIES; PHENYLEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; SLEEP APNEA SYNDROMES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 15744377838     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000153794.52852.04     Document Type: Conference Paper

References (26)

1. Fletcher EC. Invited review: physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 2001;90:1600-1605.
2. Wolk R Somers VK. Cardiovascular consequences of obstructive sleep apnea. Clin Chest Med. 2003;24:195-205.
3. Minchenko A, Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem. 2000;208:53-62.
4. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17:61-66.
5. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension. 2001;37:511-515.
6. Lariviere R Lebel M. Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol 2003;81:607-621.
7. Touyz RM Schiffrin EL. Role of endothelin in human hypertension. Can J Physiol Pharmacol. 2003;81:533-541.
8. Freedman NJ, Ament AS, Oppermann M, Stoffel RH, Exum ST, Lefkowitz RJ. Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity. J Biol Chem. 1997;272:17734-17743.
9. Thakali K, Fink GD, Watts SW. Arteries and veins desensitize differently to endothelin. J Cardiovasc Pharmacol 2004;43:387-393.
10. Fletcher EC. Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep. 2003;26:15-19.
11. Li HY, Wang PC, Hsu CY, Chen NH, Fang TJ. Changes of sleep-disordered breathing after laryngeal surgery in patients with bilateral vocal fold paralysis. Eur Arch Otorhinolaryngol. 2004 Sep 15; [Epub ahead of print].
12. Bradford A. Effects of chronic intermittent asphyxia on haematocrit, pulmonary arterial pressure and skeletal muscle structure in rats. Exp Physiol. 2004;89:44-52.
13. Peng Y, Yuan G, Overholt JL, Kumar GK, Prabhakar NR. Systemic and cellular responses to intermittent hypoxia: evidence for oxidative stress and mitochondrial dysfunction. Adv Exp Med Biol. 2003;536:559-564.
14. Naik JS, Barley S, Resta TC, Walker BR. Pressure-induced smooth muscle cell depolarization in pulmonary arteries from control and chronically hypoxic rats does not cause myogenic vasoconstriction. J Appl Physiol. 2004 Oct 22; [Epub ahead of print].
15. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
16. Claing A, Shbaklo H, Plante M, Bkaily G, Orleans-Juste P. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. Br J Pharmacol. 2002;135:433-443.
17. Delarue C, Jouet IR, Gras M, Galas L, Fouraier A, Vaudry H. Activation of endothelin-A receptors in frog adrenocortical cells stimulates both calcium mobilization from intracellular stores and calcium influx through L-type calcium channels. Endocrinology. 2004 Sep 23; [Epub ahead of print].
18. Scherer EQ, Herzog M, Wangemann P. Endothelin-1-induced vasospasms of spiral modiolar artery are mediated by rho-kinase-induced Ca(2+) sensitization of contractile apparatus and reversed by calcitonin gene-related peptide. Stroke. 2002;33:2965-2971.
19. Zhang WM, Yip KP, Lin MJ, Shimoda LA, Li WH, Sham JS. ET-1 activates Ca2+ sparks in PASMC: local Ca2+ signaling between inositol trisphosphate and ryanodine receptors. Am J Physiol Lung Cell Mol Physiol. 2003;285:L680-L690.
20. Corno AF, Milano G, Morel S, Tozzi P, Genton CY, Samaja M, von Segesser LK. Hypoxia: unique myocardial morphology? J Thorac Cardiovasc Surg. 2004;127:1301-1308.
21. Gozal E, Sachleben LR Jr, Rane MJ, Vega C, Gozal D. Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms. Am J Physiol Cell Physiol. 2004 Nov 10; [Epub ahead of print].
22. Shaw L, O'Neill S, Jones CJ, Austin C, Taggart MJ. Comparison of U46619-, endothelin-1- or phenylephrine-induced changes in cellular Ca2+ profiles and Ca2+ sensitisation of constriction of pressurised rat resistance arteries. Br J Pharmacol. 2004;141:678-688.
23. Cowen T, Burnstock G. Quantitative analysis of the density and pattern of adrenergic innervation of blood vessels. A new method. Histochemistry. 1980;66:19-34.
24. Nilsson H, Goldstein M, Nilsson O. Adrenergic innervation and neurogenic response in large and small arteries and veins from the rat. Acta Physiol Scand. 1986;126:121-133.
25. Bananian S, Lehrman SG, Maguire GP. Cardiovascular consequences of sleep-related breathing disorders. Heart Dis. 2002;4:296-305.
26. Phillips BG, Somers VK. Sleep disordered breathing and risk factors for cardiovascular disease. Curr Opin Pulm Med. 2002;8:516-520.